Zhitong Finance App News, Fosun Pharmaceutical (02196.HK) issued an announcement according to the “National Basic Medical Insurance, Maternity Insurance and Work Injury Insurance Drug Catalogue (2025)” (hereinafter referred to as the “2025 National Health Insurance Catalogue”) issued by the National Health Security Administration and the Ministry of Human Resources and Social Security on December 7, 2025 and the “Commercial Health Insurance Innovative Drug Catalogue (2025)” (hereinafter referred to as the “Commercial Insurance Innovative Drug Catalogue”), Shanghai Fosun Pharmaceutical (Group) Co., Ltd. and its holding subsidiaries/units (hereinafter referred to as the “Group”) ) Many marketed products were included or involved for the first time

Zhitongcaijing · 2d ago
Zhitong Finance App News, Fosun Pharmaceutical (02196.HK) issued an announcement according to the “National Basic Medical Insurance, Maternity Insurance and Work Injury Insurance Drug Catalogue (2025)” (hereinafter referred to as the “2025 National Health Insurance Catalogue”) issued by the National Health Security Administration and the Ministry of Human Resources and Social Security on December 7, 2025 and the “Commercial Health Insurance Innovative Drug Catalogue (2025)” (hereinafter referred to as the “Commercial Insurance Innovative Drug Catalogue”), Shanghai Fosun Pharmaceutical (Group) Co., Ltd. and its holding subsidiaries/units (hereinafter referred to as the “Group”) ) Many marketed products were included or involved for the first time